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Abstract
The heat-shock response, a fundamental defense mechanism against proteotoxic stress, is regulated by a family of heat-
shock transcription factors (HSF). In humans HSF1 is considered the central regulator of heat-induced transcriptional
responses. The main targets for HSF1 are specific promoter elements (HSE) located upstream of heat-shock genes encoding
cytoprotective heat-shock proteins (HSP) with chaperone function. In addition to its cytoprotective function, HSF1 was
recently hypothesized to play a more complex role, regulating the expression of non-HSP genes; however, the non-
canonical role of HSF1 is still poorly understood. Herein we report that heat-stress promotes the expression of
cyclooxygenase-2 (COX-2), a key regulator of inflammation controlling prostanoid and thromboxane synthesis, resulting in
the production of high levels of prostaglandin-E2 in human cells. We show that heat-induced COX-2 expression is regulated
at the transcriptional level via HSF1-mediated signaling and identify, by in-vitro reporter gene activity assay and deletion-
mutant constructs analysis, the COX-2 heat-responsive promoter region and a new distal cis-acting HSE located at position
22495 from the transcription start site. As shown by ChIP analysis, HSF1 is recruited to the COX-2 promoter rapidly after
heat treatment; by using shRNA-mediated HSF1 suppression and HSE-deletion from the COX-2 promoter, we demonstrate
that HSF1 plays a central role in the transcriptional control of COX-2 by heat. Finally, COX-2 transcription is also induced at
febrile temperatures in endothelial cells, suggesting that HSF1-dependent COX-2 expression could contribute to increasing
blood prostaglandin levels during fever. The results identify COX-2 as a human non-classical heat-responsive gene, unveiling
a new aspect of HSF1 function.
Citation: Rossi A, Coccia M, Trotta E, Angelini M, Santoro MG (2012) Regulation of Cyclooxygenase-2 Expression by Heat: A Novel Aspect of Heat Shock Factor 1
Function in Human Cells. PLoS ONE 7(2): e31304. doi:10.1371/journal.pone.0031304
Editor: Harm Kampinga, University Medical Center - University of Groningen, The Netherlands
Received November 3, 2011; Accepted January 6, 2012; Published February 8, 2012
Copyright:  2012 Rossi et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants from the Italian Ministry of Health, ISS projects ‘Ricerca Oncologica’ [N. 7OCF/7] and ‘Alleanza contro il Cancro’ [N.
ACC12], and the EU-EICOSANOX project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the
manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: santoro@bio.uniroma2.it
. These authors contributed equally to this work.
Introduction
The heat shock response (HSR) is a finely regulated and highly
conserved mechanism, which protects living cells against proteo-
toxic stress induced by different types of environmental and
pathological conditions, initiating a regulatory cascade for
recovery and adaptation [1]. This occurs by a nearly instantaneous
induction of a set of genes, known as heat shock (HS) genes,
leading to expression of cytoprotective heat shock proteins (HSP),
which is proportional to the intensity and duration of stress [2,3].
Studies on the heat shock response have revealed insights on the
stress-sensing cellular devices and on the role of heat shock
proteins in repairing protein damage.
The HSR is regulated by a family of heat shock transcription
factors (HSFs) that are expressed and maintained in an inactive
state under non-stress conditions. Mammalian genomes encode
three homologues of HSF (HSF1, HSF2 and HSF4) regulating
HSP expression. Among these HSF1 is considered to be the
paralog responsible for regulating the heat-induced transcriptional
response [4]. HSF2 has also been reported to contribute to
inducible expression of heat shock genes through interplay with
HSF1 [5].
HSF1 is generally found in the cytoplasm as an inert monomer
lacking transcriptional activity; both DNA-binding and transcrip-
tional transactivation domains are repressed through intramolec-
ular interactions and constitutive serine phosphorylation [6]. Upon
exposure to heat shock and other types of stresses, which cause
protein damage, HSF1 is derepressed in a stepwise process that
involves oligomerization of HSF1 monomers to a trimeric state,
localization to the nucleus, inducible phosphorylation and
sumoylation, and binding of nuclear-localized trimers to DNA
sequences known as heat shock elements (HSE). Functional HSE
sequences are characterized by an array of inverted repeats of the
pentameric motif nGAAn and are usually located in the proximal
region of HSF1-responsive gene promoters.
Binding of HSF1 to HSE sequences is followed by a rapid shift
in the transcriptional program resulting in the high rates of
transcription of cytoprotective heat shock genes, which include
molecular chaperones of the HSP70 and HSP90 families, HSP27
and other proteins of the network. High rates of transcription are
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when either the stress signal is removed or damaged proteins are
no longer generated, the HSR attenuates rapidly, with subsequent
conversion of HSF1 back to the monomeric state [7]. Inducible
acetylation has also been recently shown to negatively regulate
DNA binding activity [8].
Although HSF1 was originally identified as the master regulator
of HSP genes, recent studies have indicated an expanding role of
this factor, providing evidence that, in some cases, HSF1 may also
control the expression of genes with non-chaperone function, some
of which participate in the regulation of inflammatory and
immune responses [9,10,11]. Based on these observations, we
investigated the effect of heat stress on the expression of
cyclooxygenase 2 (COX-2), a key enzyme in the regulation of
the inflammatory response, catalyzing the rate-limiting step in the
synthesis of prostanoids and thromboxanes [12,13]. Herein we
report that in human cells heat stress induces the expression of
COX-2 at the transcriptional level, by a mechanism involving
HSF1-binding to a distal cis-acting HSE regulatory sequence
located in the promoter at position 22495 from the transcription
start site.
Results
Heat stress induces the expression of the COX-2 gene in
human cells
To investigate the effect of heat stress (HS) on COX-2
expression, primary blood monocytes from healthy donors, human
umbilical vein endothelial cells (HUVECs) and two human cancer
cell lines, HCT116 colorectal adenocarcinoma and lymphoblas-
toid Jurkat cells, known to express low levels of COX-2 mRNA
and protein [14,15,16,17], were incubated at 43uC for 40 min and
allowed to recover at 37uC for 90 min. At this time, total RNA was
extracted and levels of COX-2, COX-1 and b-actin mRNA were
analyzed by RT-PCR and real-time PCR. As shown in Fig. 1A
and B, heat treatment resulted in an increase of COX-2 mRNA
levels in all cells analyzed; however, HUVECs and HCT116 cells
were found to be more sensitive to COX-2 induction by heat as
compared to human monocytes and Jurkat cells. Differently from
COX-2, no changes in COX-1 levels were detected in the same
samples (Fig. 1A). As expected HS also caused an increase in
HSP70 mRNA levels in all cell types (data not shown). The
elevated COX-2 mRNA levels found in heat-stressed endothelial
cells, together with the recent observation that thermal stress may
influence endothelium functions [18], prompted us to analyze the
mechanism of COX-2 induction by heat in the endothelium.
Induction of COX-2 expression and PGE production by
heat stress in endothelial cells
To gain further insight into the regulation of COX-2 induction
in response to heat stress we initially performed kinetics studies on
COX-2 mRNA and protein expression in endothelial cells.
HUVECs were either kept at 37uC or were subjected to HS at
43uC for 40 min. At the end of heat treatment, or at different
times during the recovery period at 37uC, total RNA was analyzed
for COX-2, COX-1, HSP70 and b-actin mRNA levels by RT-
PCR and real-time PCR. In parallel samples whole-cell extracts
were analyzed for levels of COX-2, HSP70 and b-actin proteins
by Western blot. As shown in Fig. 2A and B, COX-2 mRNA levels
started to accumulate at the end of heat treatment, reaching
maximal levels at 1,5 hour during the recovery period, and went
back to control levels after 6 hours. No change in COX-1 mRNA
levels were observed at all times, while HSP70 mRNA started to
accumulate at the end of heat treatment and went back to control
levels after 8 hours of recovery at 37uC. Parallel with COX-2
mRNA, COX-2 protein levels started to increase at the end of
heat treatment, reached maximal levels at 1,5-3 hours during the
recovery period and went back to control levels after 6 hours at
37uC. This is expected since COX-2 protein is typically present for
only a few hours after its synthesis, due to the presence of an
instability element located upstream of the C-terminus that targets
the protein to the ER-associated degradation system and the
proteasome [19]. HSP70 protein started to accumulate at the end
of heat treatment, but, differently from COX-2, continued to
accumulate for at least 8 hours after HS.
The subcellular localization of COX-2 in heat-stressed
endothelial cells was examined by confocal microscopy. HUVECs
growing on coverslips were subjected to heat stress as described
above and allow to recover at 37u for 3 h. As shown in Fig. 2D,
under normal conditions COX-2 protein was found to be
expressed at low levels and to be localized mainly within the
nucleus of HUVECs, as previously reported [20]. In heat-stressed
cells, a strong nuclear COX-2 immunofluorescence signal was
detected at 3 h after treatment; in addition, increased COX-2
levels were found to be diffusely distributed throughout the
cytoplasm (Fig. 2D).
To determine whether COX-2 up-regulation resulted in an
enhancement of COX-2 metabolites generation, the production of
prostaglandin E2 (PGE2), a major COX-2 metabolite, was
determined. HUVECs were heat stressed as described above
and, at different times during the recovery period, whole-cell
extracts were analyzed for levels of COX-2 by Western blot, and
PGE2 production was determined in the culture supernatants by
ELISA. As positive control, HUVECs were stimulated with IL-1b
and COX-2 levels and PGE2 production were determined 6 hours
Figure 1. Heat stress induces COX-2 mRNA expression in
human cells. Human endothelial cells (HUVEC), peripheral blood
monocytes (MW), colon carcinoma cells (HCT116) and T lymphoblastoid
cells (Jurkat) were either kept at 37uC (- HS) or incubated at 43uC for
40 min (+ HS) and allowed to recover at 37uC for 90 min. At this time,
total RNA was extracted and levels of COX-2, COX-1 and b-actin mRNA
were analyzed by RT-PCR (A) and real-time PCR (B). For real-time PCR,
relative quantities of COX-2 RNAs were normalized to b-actin. All
reactions were made in duplicates using samples derived from at least
three biological repeats. Error bars indicate 6 S.D. Fold induction was
calculated by comparing the induction of the indicated genes in the
treated samples to the relative control, which was arbitrarily set to 1.
*=P,0.05.
doi:10.1371/journal.pone.0031304.g001
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dependent increase in PGE2 production. As early as 2 hours
during the recovery period the increase in PGE2 production was
comparable to that reached in HUVECs stimulated with IL-1b for
6 hours, despite the fact that higher levels of COX-2 were detected
in IL-1b-treated cells. PGE2 levels continued to rise until 4–
6 hours after stress. Levels of the prostacyclin metabolite 6-keto
PGF1a were also found to be increased in the same samples (Rossi
A., personal communication).
To determine whether heat-induced PGE2 production was
dependent on de-novo synthesis of heat-induced COX-2 expression
or was the consequence of increased prostanoid secretion,
Figure 2. Kinetics of heat-induced COX-2 expression and PGE production in endothelial cells. A–C. HUVECs were either kept at 37uC
(Control) or were subjected to heat shock (HS) at 43uC for 40 min. At the end of heat treatment, or at 1.5, 3, 6 and 8 hours during the recovery period
at 37uC, total RNA was analyzed for COX-2, COX-1, HSP70 and b-actin mRNA by RT-PCR (A) and real-time PCR (B). In parallel samples whole-cell
extracts were analyzed for levels of COX-2, HSP70 and b-actin proteins by Western blot (C). (D) Immunofluorescence of HUVECs kept at 37uC (Control)
or subjected to heat shock at 43uC for 40 min and allowed to recover at 37uC for 3 hours (HS) labeled with anti-COX-2 antibodies (red). Nuclei are
stained with DAPI (blue). The overlay of the two fluorochromes is shown (Merge). Images were captured with a Leica confocal microscope TCS 4D
system. (E) HUVECs were either kept at 37uC (Control) or were subjected to heat shock (HS) at 43uC for 40 min. At 2, 4 and 6 hours during the
recovery period at 37uC, whole-cell extracts were analyzed for levels of COX-2 and b-actin proteins by Western blot (top panel), and PGE2 production
in the culture supernatants was determined by ELISA (bottom panel). In parallel samples treated with IL-1b (20 ng/ml) COX-2 levels and PGE2
production were determined 6 hours after treatment. (F) HUVECs were treated with the COX-2 inhibitor NS398 (100 mM) or DMSO vehicle either
1 hour before or during HS at 43uC for 40 min. At 2 hours during the recovery period at 37uC, PGE2 production was determined by ELISA. Data in E
and F represent the mean6S.D. of triplicate samples from a representative experiment of three with similar results. *=P,0.01. (G) HUVECs were
treated with actinomycin D (AMD) (5 mg/ml) or vehicle and, after 45 min, were either subjected to heat shock (HS) at 43uC for 40 min or left
untreated. At 1,5 hour during the recovery period at 37uC, total RNA was extracted and levels of COX-2 and b-actin mRNA were analyzed by real-time
PCR. For real-time PCR (panels B and G), relative quantities of COX-2 RNAs were normalized to b-actin. All reactions were made in duplicates using
samples derived from at least three biological repeats. Error bars indicate 6 S.D. Fold induction was calculated as described in Fig. 1.
doi:10.1371/journal.pone.0031304.g002
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or DMSO vehicle either 1 hour before or during HS at 43uC for
40 min. After a 2 hour recovery period at 37uC, PGE2 production
was determined by ELISA. As shown in Fig. 2F, treatment with
NS398 resulted in a complete block of PGE2 production,
demonstrating that heat-induced COX-2 is responsible for
prostanoid synthesis during heat stress.
Both mRNA de novo transcription and increased mRNA stability
have been reported to be involved in the induction of COX-2
[21,22,23]. To determine whether gene transcription was required
for COX-2 induction by heat, HUVECs were pretreated with
actinomycin D (5 mg/ml) for 45 min and then subjected to HS at
43uC for 40 min. At 1,5 hours during the recovery period at 37uC,
total RNA was extracted and levels of COX-2 and b-actin mRNA
were analyzed by real-time PCR. As shown in Fig. 2G, the
increases in COX-2 mRNA level was abolished by actinomycin D
treatment, indicating that COX-2 mRNA induction by heat
involves de novo gene transcription.
Identification of the promoter elements responsible for
COX-2 gene regulation by heat
The regulation of COX-2 gene (Ptgs2) transcription is very
complex, involving distinct signaling pathways and different
controlling mechanisms depending on the specific stimulus and
the cell type. Sequence analysis of the 59-flanking region of the
human COX-2 gene has identified several potential transcription-
al cis-acting regulatory elements, located in the proximal region of
the COX-promoter within the first 550 bp upstream of the
transcriptional start site (TSS), with the exception of a peroxisome
proliferator response element (PPRE), that is located at 23721 to
23707 upstream of TSS [22]. To identify novel heat-regulated
elements in the COX-2 promoter, we performed a computer-
based sequence analysis of the 59-flanking region. As shown in
Fig. 3A, three regions highly conserved in human and mouse were
identified between positions 23120 and 21396 upstream of the
TSS.
To investigate the role of these regions in COX-2 regulation by
heat, a series of 59-deletion constructs including all three (FL-
COX2-PGL3, FL), two (-2221-COX2-PGL3, Del1), one (-1787-
COX2-PGL3, Del2) or none (-1396-COX2-PGL3, Del3) of the
highly conserved regions were subcloned into the pGL3 reporter
vector and used for functional analysis (Fig. 3B). HUVECs and
HCT116 cells were transiently transfected with the different
constructs; after 24 h, transfected cells were either subjected to
heat stress at 43uC for 40 min or stimulated with the COX-2
inducer TPA (12-O-tetradecanoylphorbol 13-acetate) as positive
control. Luciferase activity was determined after a 6 h recovery
period at 37uC. As shown in Fig. 3C and D, heat stress induced
reporter activity in both HUVEC or HCT116 cells transfected
with the FL construct, while no significant transcriptional activity
Figure 3. Identification of the promoter region responsible for COX-2 gene regulation by heat. (A) Schematic representation of human-
mouse conserved sequences in the upstream COX-2 gene promoter region identified by using ECR Evolutionary Conserved Regions (ECR) browser
(http://ecrbrowser.dcode.org/). X-axis represents base position from transcription start site (+1), and y-axis indicates percentage identity in a window
of 100 nucleotides centered on that position. Black areas represent conserved regions that meet ECR default criteria (ECR similarity $70%, ECR length
$100 nucleotide). The arrows indicate the nucleotide coordinates of the full length and deletion constructs (Del1, Del2 and Del3) represented in B.
(B) Schematic representation of the full-length (FL) and three deletion constructs containing different portions of the 59-flanking sequences of the
human COX-2 promoter region (Del1, Del2 and Del3). The negative numbers (-) noted in each construct indicate the distance from the transcription
start site. (C,D) Full-length and deletion constructs subcloned into the PGL3-Basic Vector upstream from the luciferase gene were transfected in
HUVEC (C) and HCT116 (D) cells. After 24 h cells were subjected to heat shock (43uC for 40 min) (filled bars), treated with 25 ng/ml TPA (dashed bars)
or left untreated (empty bars). Whole-cell extracts were analyzed for luciferase activity after 6 h recovery at 37uC. The data, expressed as fold
induction of untreated control, represent the mean of quadruplicate samples from two independent experiments. Error bars indicate 6 S.D.
*=P,0.05.
doi:10.1371/journal.pone.0031304.g003
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constructs, suggesting that the region spanning between 23120
to 22221 may contain the element/elements responsible for heat-
induced COX-2 transcriptional activity. Differently from heat
stress, TPA was able to induce significant reporter activity in cells
transfected with all four constructs. These results are consistent
with the findings of others who identified the elements responsive
to TPA in the first 550 bp upstream the TSS [22].
To identify the enhancer elements responsible for HS-induced
COX-2 gene expression, the identified region spanning between
23120 to 22221 was analyzed by TFSEARCH version 1.3
(Yutaka Akiyama, TFSEARCH: Searching Transcription Factor
Binding Sites, http://www.cbrc.jp/research/db/FSEARCH.
html) [24]. Using a cut-off threshold score of 85%, TFSEARCH
prediction analysis identified several transcription factors that may
bind to this region. Among these factors, one putative HSF1-
binding element located at position 22495 (HSE) and one
putative GATA-binding element (GATA-RE) located at 22570
from the transcription start site were detected (Fig. 4A). Since
HSEs represent the target for HSF1-mediated heat shock response
regulation and GATA response elements were reported to be able
to transactivate the HSP70 promoter [25], we focused our
Figure 4. Characterization of distal cis-acting HSE regulatory elements in the human COX-2 gene. (A) Nucleotide sequence of human
COX-2 promoter region between 23120 and 22221, as indicated in Fig. 3A. Location of putative binding sites for HSF1 and GATA transcription
factors in the COX-2 promoter identified by TFSEARCH are indicated. (B) Schematic representation of the wild type COX-2-PGL3 construct (WT) and
the D-HSE-D-GATA, D-HSE and D-GATA PGL3 constructs. (C,D) WT, D-HSE-D-GATA, D-HSE and D-GATA deletion constructs (shown in B) were
transfected in HUVEC (C) and HCT116 (D) cells. After 24 h cells were subjected to heat shock (43uC for 40 min) (+ HS), or left untreated (- HS). Whole-
cell extracts were analyzed for luciferase activity after 6 h recovery at 37uC. The data, expressed as fold induction of untreated control, represent the
mean of quadruplicate samples from two independent experiments. Error bars indicate 6 S.D. *=P,0.05.
doi:10.1371/journal.pone.0031304.g004
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deletion analysis. A series of constructs deleted for the binding
elements for HSF1 (D-HSE), GATA1 (D-GATA), and for both
HSF1 and GATA1 (D-HSE-D-GATA) were therefore generated
(Fig. 4B).
The D-HSE-D-GATA, D-HSE and D-GATA or the wild-type
(WT) constructs were transiently transfected in HUVEC and
HCT116 cells. At 24 h after transfection, cells were subjected to
heat stress, and the promoter activity was determined as described
above. As shown in Fig. 4C and D, the deletion of both HSE and
GATA response elements resulted in an almost complete block of
heat-induced transcription. Deletion of the GATA element alone
did not alter the ability of the COX-2 promoter to respond to heat;
on the other hand, deletion of the HSE element prevented
transcriptional activation, identifying the HSE sequence present in
the COX-2 promoter as a critical element for heat-induced COX-
2 transcription.
HSF1 binds directly to the COX-2 promoter in vitro and in
vivo
The identification of a functional HSE element in the COX-2
promoter suggested that HSF1 might participate directly in the
regulation of COX-2 expression.
Heat stress is known to activate HSF1 as early as few minutes.
To establish the role of HSF1 in COX-2 up-regulation by heat,
kinetics experiments were performed to determine HSF1 DNA-
binding activity to the COX-2 promoter in vitro and in vivo.
HUVECs were subjected to a 40 min heat shock at 43uC and then
allowed to recover at 37uC. At different times during heat
treatment or the recovery period, whole-cell extracts were
analyzed for HSF1 DNA-binding activity by EMSA using a large
DNA fragment of 100 bp (from 22579 to 22480) of the COX-2
promoter region comprising binding sites for the GATA and
HSF1 transcription factors (Fig. 5A). In parallel, the same samples
were analyzed for HSF1 DNA-binding activity by EMSA using a
30 bp oligonucleotide containing an ideal HSE from the HSP70
promoter [26].
A specific slower-migrating mobility complex, subsequently
identified as HSF1 (see below), was found to appear as early as
20 min in the heat-shocked samples using the COX-2 promoter
derived 100 bp sequence (Fig. 5B, upper panel). The slower-
migrating mobility complex persisted up to 40 min of the recovery
period, after which time it started to attenuate. This kinetics is
consistent with the kinetics of HSF1 phosphorylation/dephos-
phorylation, which is known to be strictly associated with HSF1-
DNA binding activity (Fig. 5B middle panel) [27]. A similar DNA-
binding pattern was obtained when the ideal HSE probe was used
(Fig. S1). Similarly to the DNA-binding analysis using the ideal
HSE element, two faster migrating bands present in both heat-
treated and control samples representing the non-specific (NS) and
the constitutive HSE binding activity (CHBA) respectively [26],
were detected also using the COX-2 promoter derived sequence.
To determine whether HSF1 was involved in the formation of
the slower-migrating mobility complex observed in Fig. 5B, a
super-shift analysis was performed using specific polyclonal anti-
HSF1 antibodies. As shown in Fig. 5C, the complex was selectively
super-shifted in the presence of anti-HSF1 antibodies, indicating
that HSF1 is the primary component of the heat-induced DNA
binding activity observed.
To investigate whether HSF1 is recruited to the COX-2 gene
promoter, HUVECs were subjected to a 40 min heat shock at
43uC and then allowed to recover at 37uC. At different times
during heat treatment and the recovery period HSF1 recruitment
to the COX-2 and HSP70 promoters was analyzed by ChIP
analysis. HSF1-coprecipitating DNA was analyzed by PCR
(Fig. 5D) and real-time PCR (Fig. 5E) with promoter-specific
primers amplifying the COX-2 and HSP70 promoters respective-
ly, and the rate of amplification was verified using cross-linked, not
immunoprecipitated chromatin. The specificity of chromatin
immunoprecipitation was determined by using a control unrelated
antibody. Consistently with the DNA-binding activity revealed by
EMSA (Fig. 5B, upper panel), HSF1 was recruited to the COX-2
promoter during heat treatment and for at least 90 min of the
recovery period at 37uC (Fig. 5D,E upper panels). A similar
kinetics of HSF1 recruitment was observed also for the HSP70
promoter (Fig. 5D,E lower panels).
An identical set of experiments was performed in HCT116 cells.
As shown in Fig. S2, the results obtained were comparable to the
ones described above for HUVECs. In addition, heat-induced
COX-2 mRNA expression was greatly reduced in HCT116 cells
in which HSF1 expression was stably suppressed by RNA
interference (Fig. S3), confirming an important role of this factor
in heat-regulated COX-2 transcription.
COX-2 expression is induced at febrile temperatures in
endothelial cells
Partial activation of HSF1 has been described during exposure
to febrile, sub-heat shock temperatures [28,29,30,31]. To
investigate whether COX-2 expression may be induced at febrile
temperatures in endothelial cells, HUVECs were either kept at
37uC or were incubated at 40 and 41uC for 8 hours. At different
times after treatment total RNA was extracted and levels of COX-
2, HSP70 and b-actin as control were analyzed by real-time PCR.
As shown in Fig. 6A, COX-2 expression was increased, reaching
maximal levels at 8 hours of continuous exposure to physiological
fever temperature. At this time a modest increase in COX-2
protein level and PGE2 production was also observed (Fig. S4);
however, the effect of febrile temperatures on the kinetics of
different COX-2 metabolites production needs to be further
investigated. Interestingly, the kinetics of heat-induced COX-2
expression differed from HSP70 mRNA accumulation, that, as
expected, reached a pick at 2–3 hours after exposure (Fig. 6B).
Discussion
Cyclooxygenases-1 and -2 (COX-1 and COX-2), also known as
prostaglandin (PG) endoperoxide synthase, are heme-containing
ER membrane-bound N-glycoproteins that catalyze the commit-
ted step in prostaglandin formation. COX-1 and 22 convert
arachidonic acid, hydrolyzed from cell membrane phospholipids
by a phospholipase A2 (PLA-2), to prostaglandin endoperoxide H2
(PGH2), the precursor of thromboxanes, prostacyclin and different
prostaglandins [23,32]. COX-1 is constitutively expressed in
almost all mammalian tissues under basal conditions, while
COX-2 expression is highly restricted (except for kidneys, seminal
vesicles and certain areas of the brain), but can be dramatically
upregulated following the appropriate stimuli [22]. In addition,
differences in regulation of the COX enzymes at the post-
transcriptional and post-translational levels also contribute signif-
icantly to their distinct patterns of expression. COX-1 mRNA and
COX-1 protein are very stable, whereas both COX-2 mRNA and
COX-2 protein have short half-lives. The 39-UTR of the human
COX-2 gene contains 23 copies of the ‘ATTTA’ RNA instability
element that participates in post-transcriptional regulation of
COX-2 expression [33]. On the other hand, a unique 27 amino
acid instability element located upstream of the C-terminus of
COX-2 targets this isoform to the ER-associated degradation
system and proteolysis by the cytosolic 26 S proteasome [19].
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PLoS ONE | www.plosone.org 6 February 2012 | Volume 7 | Issue 2 | e31304Figure 5. In vitro and in vivo binding of HSF1 to the COX-2 promoter. (A) Nucleotide sequence of the 100 bp (from 22579 to 22480) DNA
fragment of the COX-2 promoter region including binding sites for the GATA and HSF1 transcription factors. The 100 bp fragment was amplified by
PCR,
32P-labeled and used as probe for gel-shift analysis shown in B and C.( B) HUVECs were subjected to heat shock at 43uC or left untreated
(control). After 20 and 40 min at 43uC (HS) or at the indicated times during recovery at 37uC (recovery), whole-cell extracts were analyzed for HSF
DNA-binding activity by EMSA in a 3% polyacrylamide gel using the probe described in (A). Position of HSF-DNA binding complex (HSF), constitutive
HSE binding activity (CHBA) and non specific protein-DNA interactions (NS) are shown (upper panel). In parallel samples whole-cell extracts were
analyzed for levels of HSF1 and b-actin proteins by Western blot (lower panels). Arrow indicates the position of the low-mobility phosphorylated
HSF1 isoform. (C) Specificity of HSF1-DNA binding complexes. Whole-cell extracts from HUVECs subjected to heat shock at 43uC for 40 min were
preincubated with different dilutions of anti-HSF1 polyclonal antibodies for 15 min before supershift assay. Position of HSF, CHBA and NS are
indicated as in B.( D,E) HUVECs were subjected to heat shock at 43uC or left untreated (control). After 20 and 40 min at 43uC (HS) or at the indicated
times during recovery at 37uC (recovery), recruitment of HSF1 to the COX-2 and HSP70 promoters was analyzed by ChIP assay. (D) ChIP-enriched
DNAs using preimmune serum (IP NS IgG) or anti-HSF1 serum (IP anti-HSF1), as well as input DNAs (INPUT) were prepared, and DNA fragments of the
COX-2 gene (22629 to 22420) and HSP70 gene (2262 to 270) were amplified by PCR. (E) Quantification of ChIP assay shown in (D). Samples from at
least three independent experiments were analyzed by real time PCR. Relative promoter occupancy is expressed as fold induction of control
arbitrarily set to a value of 1. Error bars indicate 6 S.D. *=P,0.05.
doi:10.1371/journal.pone.0031304.g005
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after its synthesis.
Depending on the cell type, COX-2 expression can be rapidly
induced by a large number of stimuli, which include proin-
flammatory cytokines such as IL-1, IL-2 and TNFa, bacterial
endotoxin (LPS), growth factors, oncogenes, and tumor promoters
(TPA) [22]. The regulation of COX-2 gene transcription is very
complex, involving distinct signaling pathways and different
controlling mechanisms depending on the specific stimulus and
the cell type. The promoter region of the COX-2 gene presents
sequences of typical immediate early genes with potential
transcriptional regulatory cis-elements mainly located in the 550
nucleotide region upstream of the transcriptional start site (TSS);
these include two cyclic AMP response elements (CRE), a sterol
response element (SRE), two nuclear factor kappa B (NF-kB) sites,
an SP1 site, a CAAT enhancer binding protein C/EBP, two AP-1
sites, an E-box, and a TATA box [22]. A distal peroxisome
proliferator response element (PPRE) has also been identified at
position 23721 from the TSS [34]. The relative contribution of
each cis-acting promoter element and its interaction with
transcription factors activated by multiple signaling pathways
depends on the cell type, the stimulus and the time following the
stimulus [22].
We have now identified a new putative distal cis-acting heat
shock element (HSE) located at position 22495 from the TSS,
responsible for binding the heat-regulated factor HSF1.
We provide evidence that heat stress promotes COX-2
expression in human cells, and that this effect is mediated by
HSF1. Following heat stress at 43uC for 40 min, COX-2 mRNA
levels start to accumulate at the end of heat treatment, reaching
maximal levels at 1,5 hour during the recovery period. Similarly to
the effect described for other COX-2 inducers, heat-induced
COX-2 expression is transient, and COX-2 levels return back to
basal 6 hours after heat exposure. No change in COX-1 mRNA
levels are observed at all times after HS. Parallel with COX-2
mRNA, COX-2 protein levels were also found to increase at the
end of heat treatment, reaching maximal levels at 1,5–3 hours
during the recovery period at 37uC. Differently from the heat
shock protein HSP70, COX-2 protein returned to basal levels
after 6 hours at physiological temperature, possibly due to
proteolysis by the 26 S proteasome.
Both mRNA de novo transcription and increased mRNA stability
have been reported to be involved in the induction of COX-2
[22,23]. We have shown that heat-induced COX-2 expression is
regulated at the transcriptional level and have identified, by in vitro
reporter gene activity assay and deletion mutant constructs
analysis, the promoter region responsive to heat induction and
the position of the HSE involved. As indicated above, the new
putative cis-acting heat shock element identified was located in a
distal region of the COX-2 promoter at position 22495 from the
transcription start site. In vitro and in vivo binding of HSF1 to the
HSE identified in the COX-2 promoter was demonstrated by gel
shift analysis and chromatin immunoprecipitation analysis,
respectively. Deletion of the HSE sequence resulted in abrogation
of heat-induced COX-2 transcription, indicating that HSF1 plays
a central role in the transcriptional control of this gene during
heat-stress.
The presence of a distal HSE sequence located at 22495 from
the TSS in the COX-2 promoter adds a new element in the
complex regulation of COX-2 expression and also represents a
novel finding in heat shock regulation of human genes. In fact
the functional HSEs characterized so far in the promoters of
classical and non-classical heat-shock human genes are usually
restricted to the promoter region proximal (,1000 bp) to the
Figure 6. Time-course of COX-2 expression at febrile temperatures in endothelial cells. HUVECs were either kept at 37uC (control) or were
incubated at 40 and 41uC as described in Material and Methods. At different times total RNA was extracted and levels of COX-2 (A) and HSP70 (B)
were analyzed by real-time PCR. Relative quantities of COX-2 and HSP70 RNAs were normalized to b-actin. All reactions were made in duplicates
using samples derived from at least three biological repeats. Error bars indicate 6 S.D. Fold induction was calculated by comparing the induction of
the indicated genes in the treated samples to the relative control, which was arbitrarily set to 1.
doi:10.1371/journal.pone.0031304.g006
HSF1-Dependent COX-2 Induction by Heat
PLoS ONE | www.plosone.org 8 February 2012 | Volume 7 | Issue 2 | e31304TSS [35]. In the case of the lactate dehydrogenase promoter
HSF1 binding to a distal HSE located at 23819 from the TSS
was described following ERB2 overexpression [36]. However,
HSF1 recruitment to distal HSEs leading to transcriptional
activation under heat stress conditions has never been described
to our knowledge.
As indicated above, COX-2 transcription is dependent on the
specific stimulus and the cell type. In response to heat we also
observed different levels of COX-2 expression in different human
primary and tumor cell lines. COX-2 levels appear to be enhanced
considerably (3–4 fold as compared to control) in human
endothelial cells and HCT116 colon carcinoma cells, and to a
lesser extent in primary monocytes and lymphoblastoid cells
(Fig. 1), but not in several breast cancer cell lines (data not shown).
This effect could be due to the presence of other cell-type specific
transcription factors needed to cooperate with HSF1 in COX-2
induction. On the other hand, it can be speculated that the
differences observed in heat-induced COX-2 expression in
different cell types may reflect differences in the chromatin
modification signature associated with highly cell-type specific
histone modification patterns, which in turn can affect HSF1
binding and/or its transcriptional potential [37,38]. It has been in
fact recently demonstrated in Drosophila that the chromatin
landscape before heat shock can dictate HSF binding to target
DNA elements [39]. In the case of classical heat shock genes,
however, because of the ubiquitous and conserved nature of the
HSR, functional HSE binding sites are likely to be evolutionary
constrained at the sequence level and actively maintained in the
accessible state at the level of chromatin organization in all cell
types [39].
The possibility of interplay of different HSFs in the regulation of
COX-2 should be also considered. As indicated in the Introduc-
tion, in human cells three different HSF family members exist,
which exhibit differential specificity for different types of heat
shock elements [5,40]. This, together with cell type-specific
expression of HSFs [5,40], may be important in determining the
target genes of each heat shock factor.
COX-2 up-regulation resulted in an enhancement of COX-2
metabolites generation, as demonstrated by the production of
PGE2. It should be noted that, despite the moderate increase in
C O X - 2m R N Al e v e l( 3 – 4f o l d )a sc o m p a r e dt oas t r o n g
induction of classical heat shock genes like HSP70 (50–80 fold),
ap o t e n tb i o l o g i c a lr e s p o n s ei s achieved. In fact, as early as
2 hours after heat stress, the increase in PGE2 production was
comparable to that reached in cells stimulated with the COX-2
inducer IL-1b,a n dP G E 2 levels continued to rise until 4–
6 hours after stress. It should be noted that an increase in
arachidonic acid metabolites production, associated to stimula-
tion of a phospholipase A2 (PLA-2) activity, following heat
shock has been previously reported in mammalian cells [41]. In
the case of endothelial cells, the fact that treatment with the
selective COX-2 inhibitor NS398 resulted in a complete block
of PGE2 production, demonstrates that PGE2 production is
dependent on de-novo synthesis of heat-induced COX-2 and is
not merely the consequence of increased prostanoid secretion.
This observation, together with the previously described
increase of phospholipase A2 activity by heat, suggests the
possibility that heat stress may coordinate the entire cascade of
prostanoid synthesis by simultaneously inducing COX-2 protein
expression and stimulating PLA-2 activity to increase COX-2
substrate bioavailability.
Increased COX-2 levels have been previously observed at
elevated temperatures in vivo in murine models [42,43]. The
possibility that also in human cells COX-2 expression may be
induced in vivo at high temperatures, as in the case of burn injuries
or hyperthermic treatment of cancer, should be considered. In the
case of burns, that are known to cause the release of arachidonic
acid metabolites [44], since thermal insults activate an inflamma-
tory cascade which culminates in the infiltration of specialized cells
into injury sites, it could be hypothesized that HSF1-induced
COX-2 expression may participate in these events during the
initial phase of inflammation. Elevated temperatures are also
reached during hyperthermic treatment of tumors [45]. In
particular, in the case of whole-body hyperthermia, a procedure
used for metastatic cancer treatment, temperatures up to 42uC are
reached and maintained for about 1 hour in the entire body [46].
In this case, vascular endothelium is subjected to heat stress
conditions, which in vitro induce COX-2 expression and prosta-
glandins production. The possibility that COX-2 expression and
production of high levels of arachidonic acid metabolites may be
induced under these conditions should be taken into consideration,
especially in view of treatment with non-steroidal anti-inflamma-
tory drugs.
Interestingly, COX-2 expression was also induced at mild (40
and 41uC) temperatures in endothelial cells, reaching maximal
levels after 8 hours of exposure, suggesting the possibility that
COX-2 expression could be increased during fever. This
phenomenon could contribute to the increase in blood prosta-
glandin level that has been documented previously in the late
phase of fever [47]. The role of HSF1, as well as HSF2, which has
been recently shown to be a primary factor required for
maintaining protein homeostasis against febrile range thermal
stress in murine cells [48], on COX-2 regulation at febrile
temperatures needs to be further investigated.
Apart of the possible physiological implications, the identi-
fication of COX-2 as an HSF1-target gene opens new
perspectives on the role of this factor. HSF1 was originally
identified as the master regulator of the transcription of heat
shock genes, leading to the rapid expression of cytoprotective
heat shock proteins. In mammalian organisms during stress
conditions different HSP act in concert constituting the cell
‘‘protein repair machinery’’ preventing protein denaturation
and aggregation that are detrimental to cells, and promoting
degradation of irreversibly denaturated cytotoxic proteins
[3,49,50]. Under normal conditions, HSP also function as
chaperones that assist in protein folding [51]. Whereas it is well
established that HSF1 regulates inducible HSP expression,
recently it has become evident that the regulation of the
mammalian HSR is a more complex phenomenon than
previously thought, and in some cases HSF1 may also control
the expression of genes with non-chaperone function, some of
which participate in the regulation of the inflammatory and
immune responses, including interleukins 1b (IL-1b), 6 (IL6),
tumor necrosis factor a (TNFa) and different chemokines
[11,52,53,54]. The fact that HSF1 also regulates the expression
of an important mediator of inflammation as COX-2 reinforces
these previous observations, and brings the attention to this less
known and still poorly understood role of HSF1 during thermal
stress. It could be hypothesized that if, on one side, HSF1
activates a fundamental and highly conserved defense response
through the robust expression of classical heat shock genes with
chaperone functions to protect individual cells, on the other it
may also coordinate a different type of response to thermal
injury, through a more finely tuned, cell-type specific induction
of non-chaperone heat-responsive genes, among which COX-2.
The understanding of this different aspect of HSF1 function
may indicate new strategies in the treatment of immune and
inflammatory disorders.
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Cell culture and treatments
Primary human umbilical vein endothelial cells (HUVEC) were
purchased from Cambrex Bio Science (Walkersville, MD, USA)
and grown in EGM-2 complete medium (Cambrex Bio Science)
according to the manufacturer’s instructions. Cells were incubated
at 37uC with 5% CO2 in non-coated 100 mm BD Falcon
TM cell
culture dishes (BD Biosciences Discovery Labware). Culture
medium was changed at day 1 and every 2 days thereafter.
Monolayer cell confluence was achieved after 4–6 days of culture.
All experiments were performed using HUVEC passage 2–5.
Human colorectal adenocarcinoma (HCT116) and lymphoblas-
toid (Jurkat) cells (American Type Culture Collection) were
maintained in McCoy’s 5 A (HCT116) or RPMI 1640 (Jurkat)
medium supplemented with 10% FCS, 2 mM glutamine, and
antibiotics. Human peripheral blood monocytes, isolated and
purified from buffy coat of healthy blood donors (kindly provided
by Prof. Adorno, Haematology Division, University of Rome Tor
Vergata) as described elsewhere [10], were grown for 24 h in
RPMI 1640 medium, supplemented with 10% FCS and
antibiotics as indicated above. For heating procedures, cells were
subjected to heat shock at the indicated temperatures in a
precision water bath-W14 (Grant Instruments). For long exposure
at febrile temperatures HUVECs were incubated in automatic
CO2 incubators certified to have ,0.2uC temperature variation
and calibrated for each experiment using an electronic thermom-
eter. Selective COX-2 inhibitor NS-398, tetradecanoylphorbol 13-
acetate (TPA) and interleukin 1b (IL-1b) (Sigma) were dissolved in
dimethylsulfoxide (DMSO) and diluted in the culture medium
immediately before use. Control cells received the same amount of
vehicle.
Cloning of COX-2 promoter, preparation of 59 deletion
constructs and mutants
To generate the COX-2-PGL3 vector indicated as full-length
(FL) in this study, a pair of gene-specific primers (sense: 59-
CGGGCTAGCTGTGCTTTCGTTTATAGCCTCA-39; anti-
sense: 59-GCTAAAGCTTGGGTAGGCTTTGCTGTCTGA-
39) was designed to amplify the COX-2 gene promoter region
(spanning from 23120 upstream of the gene transcription start site
to +110) from human genomic DNA (Promega) by using Phusion
High-Fidelity DNA polymerase (Finnzymes). The reaction product
was analyzed by agarose gel electrophoresis, digested with NheI
and HindIII, and inserted upstream of the luciferase gene of the
pGL3Basic vector (Promega) to generate the FL-COX2-PGL3
(FL) construct. The -2221-COX2-PGL3 (22221, Del1), -1787-
COX2-PGL3 (21787, Del2) and -1396-COX2-PGL3 (21396,
Del3) serial deletion mutants were generated as described above.
Oligos used were: for 22221, Del1 construct, sense: 59-
CGGGCTAGCACCAGCATCCCAAATGTACC-39; for -1787,
Del2 construct, sense: 59- CGGGCTAGCAACATGGCTTCTA-
ACCCAAA-39; for 21396, Del3 construct, sense: 59- CGGG-
CTAGCGCTGTCATTTTCCTGTAATGC-39. The antisense
oligo used was the same as that used for the construction of the
FL construct. The D-HSE-COX2-PGL3 (D-HSE), D-GATA-
COX2-PGL3 (D-GATA) and D-HSE-D-GATA-COX2-PGL3 (D-
HSE-D-GATA) mutant constructs were generated by using the
QuikChange Site-Directed Mutagenesis Kit following the manu-
facturer’s instructions (Stratagene). Oligos used were: for D-HSE
construct, sense: 59-GCAGAAGGGGGCAGTAAAACTAGC-
TCTGGAAG-39, antisense: 59-CTTCCAGAGCTAGTTTTAC-
TGCCCCCTTCTGC-39; for D-GATA construct, sense: 59-AC-
ACAAAATCTGTCTTCCTAGCATCTTAGGAAAAAAGTT-
G-39, antisense: 59-CAACTTTTTTCCTAAGATGCTAGGAA-
GACAGATTTTGTGT-39. For the D-HSE-D-GATA construct,
the same oligos used for D-GATA were used on the D-HSE
construct. The nucleotide sequence of each construct was verified
by DNA sequencing.
Recombinant retroviral vectors
For HSF1 knockdown experiments, we used the RNAi-pSuper-
retro vector, containing a puromycin resistance gene for selection
of stable transfectants. The sequence of human HSF1 gene was
selected as reported before [55]. Retroviruses were produced by
transfection of 293T cells with plasmids expressing retroviral
proteins Gag-Pol, G (VSV-G pseudotype), pSUPER-retro and
HSF1i-pSUPER-retro constructs using Lipofectamine 2000 (In-
vitrogen). At 48 h after transfection, supernatants containing the
retroviral particles were collected and frozen at 270uC until use.
HCT116 cells were infected with diluted supernatant in the
presence of 8 mg/ml Polybrene overnight, and then selected with
puromycin (1 mg/ml) 48 h after infection. After 10 days in
selective medium, two pools referred to as pHCT116-pSUPER-
retro (pHCT116-retro) and pHCT116-pSUPER-retro-HSF1i
(pHCT116-HSFi) were isolated. The puromycin selective pressure
was removed 24 hours before experimental procedures.
Cell transfection and reporter assays
Transfections were performed using FuGENE HD Transfection
Reagent (Roche) for HUVEC cells and LipofectAMINE Plus
reagent (Invitrogen) for HCT116 cells according to the manufac-
turer’s protocols. For reporter gene experiments, the different
COX-2 constructs were co-transfected with a control plasmid
(pRL-TK encoding Renilla luciferase; Promega) to normalize
transfection efficiency. Transfected cells were grown for 16 h
before heat treatment and luciferase activity of quadruplicate
samples was measured in a Microplate Luminometer (Wallac-
Perkin Elmer) using Dual-Luciferase kit (Promega). COX-2
promoter firefly luciferase activity was normalized to Renilla
luciferase activity in the same sample.
Electrophoretic Mobility Shift Assay (EMSA)
The 100 bp DNA probe (shown in Fig. 5A) was prepared by
PCR amplification of the COX-2 promoter region containing the
HSF1 binding site (from 22579 to 22480) using the following
primers: sense: 59- AAAATCTGTCTGGCAATCTTCC-39, an-
tisense: 59- TCTTCCAGAGCTTTCTGTTGAG-39. This PCR
product was labeled at both ends using [c
32-P]ATP plus T4
nucleotide kinase. Whole-cell or nuclear extracts were prepared as
described [56]. Whole-cell (15 mg) and nuclear (5 mg) extracts were
incubated with a
32P-labeled probe followed by analysis of DNA-
binding activity by EMSA. Binding reactions were performed as
described [57]. Complexes were analyzed by nondenaturing 3%
polyacrylamide gel electrophoresis. Quantitative evaluation of
HSF-HSE complex formation was determined by Typhoon 8600
imager (Molecular Dynamics, Amersham Biosciences) with the use
of ImageQuant (Amersham Biosciences).
Western blot analysis
Equal amounts of protein (35 mg/sample) from whole-cell
extracts were separated by SDS/PAGE, and blotted to nitrocel-
lulose. After blocking with 5% skim milk solution, membranes
were incubated with rabbit polyclonal anti-HSF1, (Santa Cruz
Biotechnology), antibodies, or monoclonal anti-COX-2 (SC-
19999, Santa Cruz Biotechnology), anti-HSP70 (Stressgene), and
anti-b-actin (Sigma) antibodies followed by decoration with
HSF1-Dependent COX-2 Induction by Heat
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(Super Signal detection kit, Pierce).
RNA extraction, RT-PCR and real-time RT-PCR
Total RNA was prepared using Trizol (Invitrogen) as described
in the manufacturer’s protocol. For RT-PCR analysis, extracted
RNA (1 mg) was digested with 2 U of DNase I (Invitrogen) for
30 min at 37uC. Samples were reverse transcribed to cDNA with
200 U of Moloney murine leukemia virus reverse transcriptase
(RT) (Gibco-BRL Life Technologies), using 5 mg of random
primers (Invitrogen) for 1 h at 45uC in a total volume of 20 ml. RT
was inactivated at 95uC for 5 min. For each sample, an aliquot of
DNase I-digested RNA, without RT, was used as a negative
control for PCR amplification. The sequences of COX-2, COX-1,
HSP70 and b-actin primers were as follows: COX-2, sense: 59-
CAGCACTTCACGCATCAGTT-39, antisense: 59- CAGCAA-
ACCGTAGATGCTCA-39; COX-1, sense: 59- AACATGGAC-
CACCACATCCT-39, antisense: 59- TCCAGGGTAGAACTC-
CAACG -39; HSP701A, sense: 59-CTACAAGGGGGAGAC-
CAAGG-39, antisense: 59- TTCACCAGCCTGTTGTCAAA-39;
b-actin, sense: 59-GCGCTCAGGAGGAGCAAT-39, antisense:
59-GCACTCTTCCAGCCTTCC-39. Amplification was per-
formed using the following parameters: 94uC for 45 s, 60uC for
30 s, and 72uC for 45 s for 28 cycles for COX-2, COX-1 and
HSP701A, and 24 cycles for b-actin. PCR products were
electrophoresed alongside DNA Molecular Weight Marker IX
(Roche Applied Science) in 2% agarose gels and then stained with
ethidium bromide. PCR amplification was performed in a thermal
cycler GeneAmp 2400 (Applied Biosystems), using Hot-Start Taq
polymerase (QIAGEN). Real-time RT-PCR analysis was per-
formed with ABI PRISM 7000 (Applied Biosystem, USA), using
RealMasterMix ROX (Eppendorf) to prepare the reaction mixes.
Primers used for real-time PCR of human genes were identical to
the primers described above for semiquantitative RT-PCR.
Relative quantities of selected mRNAs were normalized to b-
actin in the same samples.
Chromatin Immunoprecipitation (ChIP) assay
Cells were fixed by adding formaldehyde (Sigma) to the medium
to a final concentration of 1%. After 15 min, cells were washed
with ice-cold phosphate-buffered saline (PBS) containing 1 mM
phenylmethylsulfonyl fluoride, shaken for 20 min at 4uC in Lysis
Buffer-1 (50 mM HEPES-KOH, pH 7.5, 140 mM NaCl, 1 mM
EDTA, 10% glycerol, 0.5% NP-40, 0.25% Triton X-100,
containing protease inhibitors) and harvested using a cell scraper.
After centrifugation at 3000 rpm for 10 min the pellet was
resuspended in Lysis Buffer-2 (10 mM Tris-HCl, pH 8.0, 200 mM
NaCl, 1 mM EDTA, 0.5 mM EGTA, containing protease
inhibitors) and shaken at room temperature for 10 minutes. After
centrifugation, nuclei were resuspended in Lysis Buffer-3 (50 mM
Tris, pH 8.0, 1% SDS, 5 mM EDTA), and chromatin was
sheared by sonication. After removal of nuclear debris by
centrifugation at 13,000 rpm for 5 min at 8uC, lysates were
diluted 10-fold with DB buffer (50 mM Tris pH 8.0, 5 mM
EDTA, 200 mM NaCl, 0.5% NP40) and then precleared for 3 h
using 80 ml of 50% salmon sperm-DNA saturated protein A (ss-
proteinA)-agarose beads. Immunoprecipitation was carried out at
4uC overnight, and immune complexes were collected with ss-
proteinA-agarose beads. Antibodies utilized included anti-HSF1
(Santa Cruz Biotechnologies) or pre-immune rabbit serum as
control for non-specific interaction. After washing three times with
high salt WB buffer (20 mM Tris, pH 8.0, 0.1% SDS, 1% NP-40,
2 mM EDTA, 0.5 M NaCl) and twice with low salt TE buffer
(10 mM Tris, pH 8.0, 1 mM EDTA), immunocomplexes were
eluted with TE containing 1% SDS. Protein-DNA cross-links were
reverted by incubating at 65uC overnight. After proteinase K
digestion, DNA was extracted with phenol-chloroform and
precipitated with ethanol using 15 mg of tRNA as carrier. PCR
was performed using the following primers: COX-2, sense: 59-
AAATGAACAGTGCAACATGTGA-39, antisense: 59-CGTCT-
GAAATTTGTTGGGAAA-39; HSP701A, sense: 59-CACTC-
CCCCTTCCTCTCAG-39, antisense: 59-TTCCCTTCTGAGC-
CAATCAC-39. For quantification of ChIP assays, samples from at
least three independent experiments were analyzed by real time
PCR. Data were normalized to the input DNA and DNA from
untreated cells.
PGE2 measurements
PGE2 production in the supernatants of endothelial cells was
determined by PGE2 EIA kit (Cayman Chemical Co.) according
to the manufacturer’s instructions. The results are expressed as
picograms per milliliter, calculated according to the PGE2
standard curve. All assays were performed in triplicate.
Confocal microscopy
HUVECs grown on coverslips were fixed with 4% paraformal-
dehyde and permeabilized in 0,1% Triton X-100-PBS for 10 min.
After blocking with 0,2% BSA, fixed cells were incubated with
rabbit anti-COX-2 antibody (SC-1747 Santa Cruz Biotechnology)
for 1 hour, and incubated with cy3-conjugated anti-rabbit IgG for
30 min at room temperature. Coverslips were mounted in
Vectashield medium (Vector Laboratories). Images were acquired
on a Leica confocal microscope TCS 4D system, equipped with a
100X 1.3–0.6 oil immersion objective.
Statistical analysis
Statistical analysis was performed using the Student’s t test for
unpaired data. Data are expressed as the mean 6 S.D. of
duplicate samples. P values of ,0,05 were considered significant.
Supporting Information
Figure S1 Kinetics of heat-induced binding of HUVEC
HSF1 to an HSP70 HSE in vitro. HUVECs were subjected to
heat shock at 43uC or left untreated (Control). After 20 and
40 min at 43uC (HS) or at the indicated times during recovery at
37uC (recovery), whole-cell extracts were analyzed for HSF DNA-
binding activity by EMSA in a 4% polyacrylamide gel using an
HSP70 HSE ideal probe [26]. Position of HSF-DNA binding
complex (HSF), constitutive HSE binding activity (CHBA) and
non-specific protein-DNA interactions (NS) are shown.
(TIF)
Figure S2 Analysis of in vitro and in vivo binding of
HSF1 to the COX-2 promoter in heat-stressed human
colon carcinoma cells. (A) HCT116 cells were subjected to
heat shock at 43uC or left untreated (control). After 40 min at
43uC (HS) or at the indicated times during recovery at 37uC
(recovery), nuclear extracts were analyzed for HSF DNA-binding
activity by EMSA in a 3% polyacrylamide gel using the probe
described in Fig. 5A. Position of HSF-DNA binding complex
(HSF) and non-specific protein-DNA interactions (NS) are shown.
(B) Specificity of HSF1-DNA binding complexes. Nuclear extracts
from HCT116 cells subjected to heat shock at 43uC for 40 min
were preincubated with different dilutions of anti-HSF1 polyclonal
antibodies for 15 min before electromobility supershift assay.
Position of HSF and NS are indicated as in A. (C,D) HCT116
cells were subjected to heat shock at 43uC or left untreated (C).
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recovery at 37uC (recovery), recruitment of HSF1 to the COX-2
and HSP70 promoters was analyzed by ChIP assay. (C) ChIP-
enriched DNAs using preimmune serum (IP NS IgG) or anti-
HSF1 serum (IP anti-HSF1), as well as input DNAs (INPUT) were
prepared, and DNA fragments of the COX-2 gene (22629 to
22420) and HSP70 gene (2262 to 270) were amplified by PCR.
(D) Quantification of ChIP assay shown in (C). Samples from at
least three independent experiments were analyzed by real time
PCR. Relative promoter occupancy is expressed as fold induction
of control arbitrarily set to a value of 1. Error bars indicate 6 S.D.
(TIF)
Figure S3 Stable suppression of HSF1 by RNA interfer-
ence reduces heat-induced COX-2 mRNA expression in
HCT116 cells. pHCT116-retro and pHCT116-HSFi cells were
subjected to heat shock at 43uC or left untreated (control). After
40 min at 43uC (HS) or at the indicated times during recovery at
37uC (recovery), total RNA was extracted and levels of COX-2
and HSP70 were analyzed by real-time PCR. Relative quantities
of COX-2 and HSP70 RNAs were normalized to b-actin. All
reactions were made in duplicates using samples derived from at
least three biological repeats. Error bars indicate 6 S.D. Fold
induction was calculated by comparing the induction of the
indicated genes in the treated samples to the relative control,
which was arbitrarily set to 1. (B) In parallel samples whole-cell
extracts were analyzed for levels of HSF1 and b-actin proteins by
Western blot. Arrow indicates the position of the low-mobility
phosphorylated HSF1 isoform.
(TIF)
Figure S4 Effect of exposure to febrile temperatures on
COX-2 protein levels and PGE2 production in endothe-
lial cells. HUVECs were either kept at 37uC (control) or were
incubated at 40 and 41uC as described in Material and Methods.
At 8 hours after continuous exposure at the indicated temperature
whole-cell extracts were analyzed for levels of COX-2 and b-actin
proteins by Western blot (A), and PGE2 production in the culture
supernatants was determined by ELISA (B). Data in B represent
the mean 6 S.D. of triplicate samples from a representative
experiment of two with similar results. *=P,0.05.
(TIF)
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